Beaufond Growth
-
Jul 01 2020Pharma Business propels Beaufond PLC’s 3rd Quarter 62.16 % increase in EBITDA to USD 17.736 million of against USD 10.937 million to the corresponding period of last year.
Beaufond PLC continues to pursue its development strategy and once…
Read more
